Mindfulness meditation in virtual reality to help stop smoking
Effects of Mindfulness Meditation in Virtual Reality on Craving and Smoking Cessation
This study is testing if mindfulness meditation in virtual reality can help people who want to quit smoking by reducing cravings and preventing them from going back to smoking.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | Centre Hospitalier Henri Laborit Academic / other |
| Locations | 3 sites (Iteuil and 2 other locations) |
| Trial ID | NCT05766553 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of mindfulness meditation conducted in a virtual reality environment on reducing cravings and preventing smoking relapse in individuals with tobacco use disorder. Participants will be randomly assigned to either a group receiving six weekly virtual reality meditation sessions or a control group receiving standard nicotine replacement therapies. The primary goal is to determine if the virtual reality mindfulness approach can lead to sustained smoking cessation for over 30 days. Follow-up assessments will occur at three and six months post-intervention to evaluate relapse rates.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 75 who smoke 10 to 40 cigarettes per day and have a substance use disorder as defined by DSM5 criteria.
Not a fit: Patients with significant cognitive disorders, other substance addictions, or serious medical conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could provide a novel, non-drug method for individuals seeking to quit smoking and manage cravings effectively.
How similar studies have performed: While mindfulness and virtual reality have been explored separately in smoking cessation, this specific combination is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Any patient consuming 10 to 40 cigarettes per day * Woman or man aged 18 to 75 inclusive * Substance use disorder according to the DSM5 classification * Benefit from social security or benefit from it through a third party in accordance with French law on research involving the human person * Having signed the informed consent form after having received written information. Exclusion Criteria: * Disabling cognitive disorders * Patient under 18 or over 75 years old. * Patient with a psychological disorder or a psychiatric pathology requiring specialized follow-up * Patient with addiction to another product. * Cardiological pathologies that could compromise the participation of patients, detected by an ECG (only for patients who will be randomized in the experimental group). * Advanced pulmonary, renal, and hepatic diseases, or any unstable and serious medical conditions that could compromise the patient's participation in the study, subject to the judgment of the doctor * Pregnant or breastfeeding woman * Simultaneous participation in another trial * Employee of the investigator or of the clinical trial site * Patients protected by law * Patients who do not speak the French language * People not covered by state health insurance * Patients who in the opinion of the investigator are unable to complete the questionnaires * Patient claustrophobic or anxious about using the cabin * Patient allergic to a molecule present in nicotine substitutes
Where this trial is running
Iteuil and 2 other locations
- Cabinet Médical — Iteuil, France (Recruiting)
- Cabinet médical des Couronneries — Poitiers, France (Recruiting)
- Centre Hospitalier Henri Laborit — Poitiers, France (Recruiting)
Study contacts
- Study coordinator: Nematollah JAAFARI
- Email: nemat.jaafari@ch-poitiers.fr
- Phone: +33 5 16 52 61 18
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.